Development of PEDF Protein: An Antiangiogenic Agent

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 2R44EY014769-02
Agency Tracking Number: EY014769
Amount: $775,784.00
Phase: Phase II
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
GENVEC, INC.
GENVEC, INC., 65 W WATKINS MILL RD, GAITHERSBURG, MD, 20878
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 LISA Wei
 (240) 632-5539
 LWEI@GENVEC.COM
Business Contact
 C KING
Phone: (240) 632-5537
Email: RKING@GENVEC.COM
Research Institution
N/A
Abstract
The leading major causes of blindness in the U.S. are exudative age-related macular degeneration (AMD) and proliferative diabetic retinopathy (DR). Both are due to aberrant neovascularization in the eye. PEDF (Pigment Epithelium-Derived Factor) is a poten

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government